` NANO (Nanobiotix SA) vs DAX Index Comparison - Alpha Spread

NANO
vs
D
DAX Index

Over the past 12 months, NANO has underperformed DAX Index, delivering a return of -12% compared to the DAX Index's +28% growth.

Stocks Performance
NANO vs DAX Index

Loading
NANO
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
NANO vs DAX Index

Performance Gap Between NANO and GDAXI
HIDDEN
Show

Performance By Year
NANO vs DAX Index

Loading
NANO
DAX Index
Add Stock

Competitors Performance
Nanobiotix SA vs Peers

DAX Index
NANO
ABBV
AMGN
GILD
VRTX
Add Stock

Nanobiotix SA
Glance View

Market Cap
204.3m EUR
Industry
Biotechnology

Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 100 full-time employees. The company went IPO on 2012-10-29. The firm is engaged in developing nanoparticle technology. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The firm develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) plays a seminal role in the potential cure and gives the systemic treatment a better chance to increase life expectancy. NanoXray products are developed to selectively increase the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

NANO Intrinsic Value
Not Available
Back to Top